canSAR 2026-an update to the public drug discovery knowledgebase
Nucleic Acids Res. 2026 Nov 20:gkag1144. doi: 10.1093/nar/gkag1144. Online ahead of print.
ABSTRACT
canSAR (https://cansar.ai) serves as the world’s largest public platform for cancer drug discovery and translational research. It serves as an exploration and hypothesis generation platform for drug discovery through (i) fully integrating large, multidisciplinary data from public resources, as well as bespoke curated data, creating a connected, navigable drug discovery knowledge map; and (ii) applying a suite of machine learning and AI tools to generate novel insights. We share the latest updates to canSAR highlighting growth across all data, enhancements to the predictive algorithms, and continued improvements to the user experience. We leverage our latest open science chemical handling and druggability prediction tools to provide traceable insights. An increased focus of the platform is to provide “in-line” support and guidance to drug discovery exploration. We report the first incarnation of our high-fidelity, agentic-AI-generated, context-specific summaries, which we provide across the website for all human proteins to further aid users in synthesis and distillation of key information.
PMID:43059368 | DOI:10.1093/nar/gkag1144

